• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 25
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 25
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Bye-Bye China?

    Decentralized Trials Fuel AI Revolution in Clinical Research

    Self-Medication: Flexibility for Patients and Drug Manufacturers

    The Single-Use Mixing Landscape: Evaluating Your Options

    DCAT President Talks COVID-19, Drug Manufacturing and Innovation
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Pfizer, BioNTech Enter Vax Pact with COVAX

    FDA Approves Janssen’s CABENUVA

    AGC Biologics Appoints Boulder Site GM

    Lilly Completes $1B Acquisition of Prevail

    Top BioPharma Form Accumulus Synergy
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Integrated Continuous Manufacturing ICM

    CONTINUUS Awarded $69.3M DoD Grant

    WDSrx Expands Warehouse Network

    Piramal Inks Clinical Supply Deal with Theratechnologies

    Recipharm Signs Manufacturing Deal with Enzymatica
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    WDSrx Expands Warehouse Network

    Catalent Acquires Acorda’s INBRIJA Manufacturing Operations

    Varcode, PL Developments Form Strategic ‘Smart Tag’ Pact

    COVID-19 Vaccine Distribution: The Air Cargo Industry’s Greatest Challenge

    Thermo Fisher Expands Clinical Supply Services in Europe
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Lilly Completes $1B Acquisition of Prevail

    Top BioPharma Form Accumulus Synergy

    Coating Place Wurster Fluid Bed Process Scaling

    AbbVie Licenses ProBioGen’s GlymaxX Technology

    Improving Product Profitability
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Top BioPharma Form Accumulus Synergy

    Global Biosciences Co. Selects ValGenesis VLMS

    Gene Therapy Co. Selects ValGenesis' SaaS Platform

    The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021

    Samsung Biologics Adopts Veeva Vault QMS to Unify Quality Management
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Cytovance Biologics

    Emergent BioSolutions

    Alcami

    Reed-Lane

    PCI Pharma Services
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    PCI Pharma Services

    Emergent BioSolutions

    Aphena Pharma Solutions

    Cytovance Biologics

    Syngene
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • Podcasts
    • White Papers
    • Infographics
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Breaking News

    Stevanato Group and Bexson Biomedical Collaborate

    Will develop a wearable drug delivery device for Bexson’s proprietary ketamine formulation.

    Related CONTENT
    • Janssen, TenNor Enter NTM Research Pact
    • Bioclinica Partners with Ikcon Pharma
    • EVOQ Therapeutics and Amgen Partner
    • Leukocare Starts Operations in the US
    • Life Sciences Strive for Greater Agility
    Contract Pharma Staff09.22.20
    Italy-based Stevanato Group, a producer of glass primary packaging and provider of integrated capabilities for drug delivery systems, and Bexson Biomedical Inc., a research stage company developing a subcutaneous ketamine treatment platform for pain management and mental health disorders, have signed an agreement. The collaboration will focus on developing a customized version of the SG EZ-be Pod, a wearable drug delivery device, for Bexson’s proprietary ketamine formulation, BB106. 
     
    The two companies will work closely together to produce a small, wearable, and programmable device, leveraging Stevanato Group’s broad experience in contract manufacturing and medical device innovation. This technology will pair with Bexson’s ketamine therapy to provide patients with non-opioid treatment for chronic and acute pain types.  
     
    Stevanato Group’s device is designed to enable dynamic and convenient subcutaneous delivery for patients, compared to current ketamine infusions that have a high procedural burden and high cost. Ketamine, which blocks a receptor that is fundamental in pain signaling, is already being used by doctors through in-office infusions. Healthcare providers are limited in their ability to send patients home with ketamine, which is where most patients develop opioid dependence.  Bexson’s proprietary formulation, BB106, will allow for steady-state plasma levels, which are currently only achieved by intravenous delivery in the clinic or hospital.
     
    “In the midst of a pandemic health crisis and evidence of increasing opioid addiction and overdoses, there has never been a greater need for effective non-opioid pain management. Stevanato Group has the ideal technology to deliver Bexson’s BB106 subcutaneous ketamine formulation,” said Gregg Peterson, Bexson’s co-founder and CEO.  “And beyond pain management, this partnership will create a true ketamine delivery platform that can be leveraged for a large number of future indications.”
     
    “We look forward to working with Bexson to ensure that our award-winning SG EZ-be Pod device is ideally suited to the needs of their patients. Now, more than ever, we need to enable patients to take their medications inside the comfort of their homes or while outside performing their daily activities,” commented chief business officer Mauro Stocchi, Stevanato Group. 
     
    “This design will support patient comfort with a discreet and intuitive device, and by utilizing our patented technologies, we address the importance of sustainability, while minimizing the overall cost per treatment,” added Steven Kaufman, vice-president of drug delivery systems, Stevanato Group. “This agreement with Bexson is a step forward for our device portfolio strategy and ongoing efforts to work closely with biotech and pharmaceutical companies as an integrated solution provider.”
    Related Searches
    • Drug Delivery
    Suggested For You
    Janssen, TenNor Enter NTM Research Pact Janssen, TenNor Enter NTM Research Pact
    Bioclinica Partners with Ikcon Pharma Bioclinica Partners with Ikcon Pharma
    EVOQ Therapeutics and Amgen Partner EVOQ Therapeutics and Amgen Partner
    Leukocare Starts Operations in the US Leukocare Starts Operations in the US
    Life Sciences Strive for Greater Agility Life Sciences Strive for Greater Agility
    Navigating Uncertainty: Considerations for Life Sciences 2021 Navigating Uncertainty: Considerations for Life Sciences 2021
    Orgenesis, Cure Therapeutics Form JV Orgenesis, Cure Therapeutics Form JV
    Evotec and Sartorius Partner with Curexsys Evotec and Sartorius Partner with Curexsys
    Colorcon Ventures Invests in i20 Therapeutics Colorcon Ventures Invests in i20 Therapeutics
    Tubulis, WuXi Biologics and WuXi STA Form Strategic Pact Tubulis, WuXi Biologics and WuXi STA Form Strategic Pact
    Stevanato Group Stevanato Group
    Syngene and 3DC Sign 5-year Collaboration Syngene and 3DC Sign 5-year Collaboration
    Inspecting the Unexpected Inspecting the Unexpected
    Ensuring Quality During the Transfer and Scale Up of Rx Drugs Ensuring Quality During the Transfer and Scale Up of Rx Drugs
    The Pandemic & The Pharma Industry: 3 Things to Know The Pandemic & The Pharma Industry: 3 Things to Know

    Related Breaking News

    • Breaking News | cGMP Manufacture | Collaborations & Alliances | Drug Delivery | Facilities | Industry News | Solid Dosage/Semi-solids
      Catalent Acquires Acorda’s INBRIJA Manufacturing Operations

      Catalent Acquires Acorda’s INBRIJA Manufacturing Operations

      The CDMO pays $80 million for dry powder inhaler spray drying, capsule manufacturing and packaging operations in Boston area.
      Contract Pharma Staff 01.13.21

    • Biologics, Proteins, Vaccines | Breaking News | Drug Delivery | Industry News
      iosBio Inks Exclusive Vax Platform Pact for COVID-19

      iosBio Inks Exclusive Vax Platform Pact for COVID-19

      OraPro oral delivery vaccine platform technology enables oral administration of thermally-stable, viral vector vaccines.
      Contract Pharma Staff 01.12.21

    • Breaking News | Cytotoxics and High Potency Manufacturing | Drug Delivery | Facilities | Industry News
      Inhalation CDMO Vectura Expands HPAPI Capabilities

      Inhalation CDMO Vectura Expands HPAPI Capabilities

      New facility will increase containment operations at Chippenham, UK site.
      Contract Pharma Staff 12.14.20


    • Drug Delivery | Industry News
      Recipharm, Medspray Establish JV

      Recipharm, Medspray Establish JV

      To exploit novel softmist technology for pharmaceutical applications.
      Contract Pharma Staff 11.17.20

    • Breaking News | Drug Delivery | Drug Development | Industry News
      Novo Nordisk to Acquire Emisphere Technologies

      Novo Nordisk to Acquire Emisphere Technologies

      Gains the Eligen SNAC oral delivery technology.
      Contract Pharma Staff 11.13.20

    • Breaking News | Collaborations & Alliances | Drug Delivery | Industry News | Parenterals
      Ypsomed Collaborates with Schott and Lonza

      Ypsomed Collaborates with Schott and Lonza

      Aims to deliver a comprehensive solution for wearable patch injectors.
      Contract Pharma Staff 11.10.20


    • Drug Delivery | Drug Development | Trials & Filings
      Impel NeuroPharma Submits NDA for INP104 in Acute Migraine

      Impel NeuroPharma Submits NDA for INP104 in Acute Migraine

      Leverages the company’s Precision Olfactory Delivery technology
      11.09.20

    • Biologics, Proteins, Vaccines | Breaking News | Drug Delivery | Industry News
      HHS Funds Development of Needle-free Vax Technology

      HHS Funds Development of Needle-free Vax Technology

      Patch could administer vaccines without traditional needles reducing the need for refrigeration in transport and storage, and possibly self-administration.
      Contract Pharma Staff 10.07.20

    • Breaking News | Drug Delivery | Industry News | Solid Dosage/Creams/Ointments
      Evonik Launches New Oral Drug Delivery Technology

      Evonik Launches New Oral Drug Delivery Technology

      For enteric protection and rapid release in the upper small intestine.
      Contract Pharma Staff 10.06.20


    • Breaking News | Drug Delivery | Industry News
      Lubrizol Supports Women’s Health Worldwide

      Lubrizol Supports Women’s Health Worldwide

      Awarded grant for generic contraceptive injection research to advance women’s health around the globe.
      Contract Pharma Staff 09.16.20

    • Breaking News | Drug Delivery | Industry News | Solid Dosage/Creams/Ointments
      Colorcon Launches Acryl-EZE II

      Colorcon Launches Acryl-EZE II

      Extends pH range of enteric coatings for pharmaceutical use.
      Contract Pharma Staff 07.17.20

    • Breaking News | Collaborations & Alliances | Drug Delivery | Drug Development | Industry News
      Vectura Signs Agreement with Aerami Therapeutics

      Vectura Signs Agreement with Aerami Therapeutics

      Will support the development of imatinib for the treatment of Pulmonary Arterial Hypertension
      Contract Pharma Staff 06.08.20


    • Bio News | Breaking News | Collaborations & Alliances | Drug Delivery | Industry News
      Virpax Completes pre-IND Meeting with FDA

      Virpax Completes pre-IND Meeting with FDA

      Epoladerm spray being developed with contract service company MedPharm
      Contract Pharma Staff 05.22.20

    • Breaking News | Drug Delivery | Industry News
      Kindeva Launches as an Independent Company

      Kindeva Launches as an Independent Company

      Was formerly known as 3M Drug Delivery Systems
      Contract Pharma Staff 05.04.20

    • Breaking News | Collaborations & Alliances | Drug Delivery | Industry News | Injectables | Packaging & Tracking
      Stevanato Group Collaborates with Cambridge Design Partnership

      Stevanato Group Collaborates with Cambridge Design Partnership

      The companies will develop a pen-injector for patients suffering from diabetes together.
      Contact Pharma Staff 04.28.20

    Trending
    • Integrated Continuous Manufacturing ICM
    • Pfizer, BioNTech Enter Vax Pact With COVAX
    • CONTINUUS Awarded $69.3M DoD Grant
    • Piramal Inks Clinical Supply Deal With Theratechnologies
    • AbbVie Licenses ProBioGen’s GlymaxX Technology
    Breaking News
    • Pfizer, BioNTech Enter Vax Pact with COVAX
    • FDA Approves Janssen’s CABENUVA
    • AGC Biologics Appoints Boulder Site GM
    • Lilly Completes $1B Acquisition of Prevail
    • Top BioPharma Form Accumulus Synergy
    View Breaking News >
    CURRENT ISSUE

    November/December 2020

    • Modeling Process Safety Workflows in Pharmaceutical Manufacturing Scale-Up
    • Ensuring Quality During the Transfer and Scale Up of Rx Drugs
    • Inspecting the Unexpected
    • Cold Chain Trends
    • Catering for the Complex
    • Biopharma Contract Manufacturing: Robust Growth Ahead
    • DCAT President Talks COVID-19, Drug Manufacturing and Innovation
    • The Single-Use Mixing Landscape: Evaluating Your Options
    • Self-Medication: Flexibility for Patients and Drug Manufacturers
    • Decentralized Trials Fuel AI Revolution in Clinical Research
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    NIH Study Compares Low-Fat, Plant-based to Low-Carb, Animal-Based Diet
    Gadot Positions Mineral Line for Vegan Market
    Nutritfy India to Launch Global Broadcast Channel Covering Nutrition
    Coatings World

    Latest Breaking News From Coatings World

    LINE-X Launches Dealer Program with International Truck
    PPG Reports Q4, Full-year 2020 Financial Results
    BASF Begins Implementing Ralignment of Global Business Services Unit
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Cretex Companies CEO Steps Down
    Data Show Porex's Medical Device Filtration Materials Protect Against Virus, Bacteria Spread
    Endoscopic Hemostasis Devices Market Valued at $730 Million
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Pfizer, BioNTech Enter Vax Pact with COVAX
    FDA Approves Janssen’s CABENUVA
    AGC Biologics Appoints Boulder Site GM
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Coty Appoints Chief Procurement Officer
    Lageen Tubes Launches Mono-Material PE Tube Solutions
    Jason Jones Loses Battle with Covid-19
    Happi

    Latest Breaking News From Happi

    Carol’s Daughter Adds New Hair Products
    Moroccan Gold Series Launches NuDo Shampoo
    Youbody Debuts Waterless Body Wash
    Ink World

    Latest Breaking News From Ink World

    BOBST Demonstrates Future of Flexible Packaging Production at Virtual Open House
    Morancé Soudure France Adds Comexi F2 MC 10-color Flexo Press
    AR Packaging Acquiring Firstan Holdings Ltd
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Gallus planning virtual event for March
    Lemu Group engineers mask-making machine
    Niagara Label upgrades with Nilpeter flexo press
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Freudenberg to Establish Apparel Interlining Competence Centers
    Minet Adds Spunlace Line in Romania
    Lemu Group Engineers Mask-Making Machine
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Cretex Companies CEO Steps Down
    Conformis Enters Development & Supply Agreement with SITES Medical
    Sectra, RSA Biomedical Sign Distribution Agreement for Implant Stability Tool
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    UDC Subsidiary Adesis' Website Wins 2020 MarCom Platinum Award
    Ambiq Wins IoT Semiconductor Company of the Year Award
    Ynvisible Names Michael Robinson CEO, Jani-Mikael Kuusisto SVP Ventures

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login